Overview

The COLchicine HEART Failure PRESERVED Trial (COLHEART-PRESERVED)

Status:
Recruiting
Trial end date:
2026-06-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to investigate the effects of colchicine on heart failure related health status, quality of life, and vascular and cardiac function in patients with heart failure with preserved ejection fraction (HFpEF).
Phase:
Phase 2
Details
Lead Sponsor:
Tor Biering-Sørensen
Treatments:
Colchicine